Recorded device evidence

DEONIZATION EXCHANGE TANKS, CARBON EXCHANGE TANKS (K123282): indications, design and recorded evidence

The acquired K123282 file contains product-specific indications and users, recorded comparison and differences, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 10 selected decisions under primary code FIP. 10 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K123282 ↗ · this pageDEONIZATION EXCHANGE TANKS, CARBON EXCHANGE TANKS2012-10-22 → 2013-04-25185Traditional
K250471 ↗AquaC UNO H2025-02-18 → 2025-11-14269Traditional
K251851 ↗DIASAFEplusUS (F00013010)2025-06-16 → 2025-10-09115Traditional
K252181 ↗AquaA2025-07-11 → 2025-09-0960Traditional
K250514 ↗UPT Series Medical RO Water Treatment System2025-02-21 → 2025-03-1724Special

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K123282 · PDF page 13 ↗ Source 2

The   Ultrapure        & Industrial     Services      Carbon        Exchange     Tanks   are      activated    carbon  tanks
intended  to     remove      chlorine    and     chioramines  from  the  water      to allow  safe   treatment      of
 Hemodialysis      patients.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Recorded comparison and differences

K123282 · PDF page 5 ↗ Source 3

AmeriWater      Exchange       Tanks          (K9915 19)

                            Ultrapure         & Industrial               Services,       LLC         exchange       tanks           for     dialysis        are         substantially
                            equivalent           to      the        currently      marketed         AmeniWater           Dialysis       tanks       and        have     not        altered
                            the    fundamental              scientifictechnologies                used       in        the predicate             device.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Performance evidence actually described

K123282 · PDF page 6 ↗ Source 4

A            system      performance            test       was         run       by         simulating          operational              conditions.          A  system
                     consisting          of Carbon,           and          DI     resins        was        set        in   place         and        operated.             Quality       testing      of
                     chlorine,           chloramines             and    resistivity         levels         were      monitored             to      ensure         performance.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK123282 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryDEONIZATION EXCHANGE TANKS, CARBON EXCHANGE TANKS [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantUltrapure & Industrial Services, LLC [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeFIP [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2013-04-25 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2012-10-22 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[168086] · record 7413ba666f6675d2104a744645af07768893cb481ca38addd9d83db2b0125d0b
  • [5] Complete results array / fda-decision-context:K123282 · record whole dataset partition

FDA 510(k) summary — K123282 ↗

Mon, 06 May 2013 15:19:36 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot d64573592b9f3874474de8de96e6a106acf31012b49c4c385eec5f1873caee2c

  • [2] PDF page 13 · record 8068e745626d3d5faef9a6e3a9129368ffe69ecf8380a5bb0cb5d5a458ff5cd8
  • [3] PDF page 5 · record f72d460f1a8f42c8abd901c525eebdf7ff4debf89005ca3f05f34df60ac57db5
  • [4] PDF page 6 · record 0f1387b05acb67474eda1a2f90fabad820a819e9a86463a27ada9bf783c3c87b

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services